Home > Insider Trading > Filing (0001062993-24-016894)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1623526	Stoke Therapeutics Inc.	STOK	Pharmaceutical Preparations (2834)	471144582

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1869027	Ltd International Ezbon	195 Arch. Makarios Iii Ave. Neocleous House Limassol G4 3030	No	No	Yes	No
1869057	Ltd Enterprise Horizon Blue	195 Arch. Makarios Iii Ave. Neocleous House Limassol G4 3030	No	No	Yes	No
1869331	Ltd Trustees Montrago	195 Arch. Makarios Iii Ave Neocleous House Limassol G4 3030	No	No	Yes	No
1869333	Trust Skorpios	195 Arch. Makarios Iii Ave. Neocleous House Limassol G4 3030	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-09-19	1,937,500	$14.05	8,906,181	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote

Footnotes

Blue Horizon Enterprise Ltd. ("Blue Horizon") is the direct owner of 4,967,621 shares of the issuer's common stock and Ezbon International Limited ("Ezbon") is the direct owner of 3,938,560 shares of the issuer's common stock. Skorpios Trust ("Skorpios") is the sole owner of each of Blue Horizon and Ezbon. Montrago Trustees Limited ("Montrago Trustees") is the corporate trustee of Skorpios Trust. Each of Blue Horizon and Ezbon disclaim beneficial ownership of the shares of the issuer's common stock held by the other, and each of Skorpios Trust and Montrago Trustees disclaim beneficial ownership of the issuer's securities except to the extent of their pecuniary interest therein.